DelveInsight Business Research’s latest analysis highlights the significant impact of the FDA’s approval of Pfizer and BioNTech’s updated COMIRNATY LP.8.1-adapted monovalent COVID-19 vaccine on August 26, 2025. This landmark approval marks a strategic shift toward risk-based vaccination strategies, targeting the most vulnerable populations while addressing the evolving...